From the Bench to the Future of Brain Research

Jennifer Panlilio’s years at the lab bench shapes her decision-making as a program officer funding Alzheimer’s research.

By Michelle Arauz

---

Jennifer Panlilio learned how ecological pressures ripple through communities during her bachelor’s in environmental anthropology. She then decided to do another bachelor’s in marine biology. The decision to start over and rebuild her education from ground up was not easy. But she believed the communities she cared about deserved answers grounded in scientific evidence.

That difficult decision was only the first time that Panlilio demonstrated she was willing to reorient her life in the service of a scientific goal. Over the years, she moved from social science to hard science. She began in environmental anthropology, shifting into marine biology and oceanography, and eventually pursued a Ph.D. in neuroscience. She later entered science policy, stepping away from hands-on research to help guide the work of others. Now, she is a Program Officer at the Alzheimer’s Drug Discovery Foundation, where she makes decisions that govern the distribution of funding to research projects that determine the future of brain-health science.

“Making careful, responsible decisions about which projects deserve funding is a form of accountability,” Panlilio says. “To me, that’s part of equity too. It’s making sure the knowledge we build is ultimately useful to the people who depend on it.”

Changing Funding Priorities in Alzheimer’s Research

The responsibility of communicating science at a moment when Alzheimer’s research is shifting toward private funding is the center of Panlilio’s work. Public trust is fragile; it shapes who receives care, who gets hope, and who is left battling this illness without reliable guidance. Panlilio’s arc represents the kind of scientific leadership the moment demands. As funding becomes increasingly privatized, science communication itself becomes a part of the public health work. Miscommunication leads to misinformation, widening inequities in who gets access to care and understanding.

Alzheimer’s research remains one of the most underfunded areas in neuroscience. Approximately 55 million people are living with Alzheimer’s and other forms of dementia in the United States alone. This is a number that is expected to double within the next few decades alone. The rise is linked to an aging population, emphasizing a growing risk to families, caregivers, and those who rely on reliable science and clear public communication on how to guide future decisions.

Despite all of this, advocates have argued that federal investment, reaching an all-time high of 3.8 billion dollars, has not kept pace with the rising need. Many NIH institutes must stop critical studies due to budget cuts and decreasing federal funds. These scientific projects are expensive, slow, and require sustainable funding streams to generate meaningful results. In this environment of constrained resources, program officers with research backgrounds become essential, as they are the ones who are able to ensure that limited public dollars are allocated to studies with the strongest grounding.

Alzheimer’s research demands people who come from the research world and understand its needs to design and execute it. Because Panlilio has navigated the challenges herself, she has the insight that allows her to take charge in a way that purely administrative reviewers cannot. Her background gives her the confidence to ask hard questions and what her current role requires her to do- invest in projects that will matter years down the line. Leaders like Panlilio, grounded in real scientific practice, are indispensable to this field.

As government funding decreases and laboratory funding cuts are happening, Gupta argues, the field needs people who understand the science deeply and can translate it responsibly. 

“Now, more than ever, having people who understand the science and can help distribute that money in responsible ways,” says Tripti Gupta, a senior scientist at the National Institute of Child Health and Human Development, who met Jennifer Panlilio over six years ago when Panlilio joined her lab as a postdoctoral fellow.

Panlilio’s Research, Communications, and Policy Work

Jennifer Panlilio’s first degree, in environmental anthropology from Stanford University, immersed her in stories, cultural analysis, and the ways communities interpret their surroundings. In that work, she realized she wanted to move closer to the mechanisms beneath the books. That is when she returned to school for a second undergraduate degree in marine biology and oceanography at the University of Miami.

That brought her to the lab bench, where she learned to translate raw data into real-world impact. She eventually did her Ph.D. at the Woods Hole Oceanographic Institution in a joint program between Woods Hole Oceanographic Institute and the Massachusetts Institute of Technology, studying how microscopic marine toxins could disrupt the developing nervous system.

Hanny Rivera, a marine biologist who met Jennifer Panlilio during their first year of graduate school at the Woods Hole Oceanographic Institution, recognized early on that Panlilio approached scientific problems uniquely. 

“Panlilio never shies away from a difficult job; she’s motivated by a challenge, always choosing the harder experiment over the easy publishable one, even if it meant staying in the lab until 4 am for weeks to get it right,” says Rivera.

Panlilio was adopting CRISPR — a precise gene editing technology — years before it became standard and redesigning experiments rather than adjusting settings. Rivera recalls that Panlilio’s work did not just generate results; it expanded what was scientifically possible. Her mechanistic approaches to study chemical pollutants and their neurological consequences are now part of how multiple protocols and research methods in multiple labs, seen in her 2020 paper in Environmental Health Perspectives.

Rivera says what truly sets Panlilio apart is not only her technical ability, but also her conscientiousness. Rivera describes Panlilio as a scientist who refuses shortcuts, interrogates her assumptions, and centers integrity even when no one is watching. Her drive was never about producing data quickly but producing data that held up ethically. She notes that Panlilio often chose the harder route.

Panlilio became an Intramural Communications Specialist at the National Institutes of Health before moving into her current role as a Program Officer at the Alzheimer’s Drug Discovery Foundation. She is responsible for evaluating proposals and determining where funding will have the greatest impact. Here, she is no longer just translating her own research; instead, translating the work of entire institutes. She authored public-facing features to widen access to complex science and joined policy discussions on how environmental exposures create and reinforce health inequities. In doing so, she contributed to solving scientific questions through both an environmental and a neurobiological lens.

Panlilio’s Unique Lens to Philanthropy

Panlilio’s work today lies at the point where science meets policy, philanthropy, and public need. This is a crossroad that defined the future of Alzheimer’s research. She sits in the rare space where scientific rigor, policy influence, and public communication converge. Recalling, Alzheimer’s research is entering a period shaped increasingly by private funding and uneven public understanding, largely because federal support has not kept pace with the scale of the crisis, creating gaps that private philanthropies now step in to fill.

In that environment, who interprets the science has real consequences. Panlilio brings something few people in the field can offer: the expertise of a bench scientist, the analytical discipline of a toxicologist, and the community-centered perspective of someone who trained to understand how people actually make sense of health information. She is not just translating isolated findings; she is shaping how entire bodies of research are evaluated and trusted. Her work determines whether discoveries clarify that or deepen confusion, and most importantly, whether they build public confidence or further fracture it.

What makes her indispensable is her insistence that communication is a scientific act, not an afterthought. She approaches translation with the same rigor she once brought to the laboratory bench. She is fighting against the widening inequities that arise when science is poorly explained. Tracing back to her expertise, her ability to trace a finding from the bench to its real-world implications makes her a unique tool.  Redesigning a model until it aligns with the real world continues to guide how she approaches research, mentors trainees, and, most importantly, how she thinks when translating science for the public. 

Panlilio’s graduate advisor during her time at the Woods Hole Oceanographic Institution Neelakanteswar Aluru, remembers her as well-prepared, thorough, and technically strong. She arrived not just ready to work, but she was always several steps ahead, anticipating the kinds of questions that would shape the project months later. That quality was visible early in how she approached experiments; she did not wait for direction, she built it.

Her ability to stay ahead of the science showed up in her publications as well. For example, her 2021 Scientific Reports paper on developmental neurotoxicity was selected as the National Institute of Environmental Health Sciences’ “Paper of the Month” in May of 2023, a distinction reserved for work that shifts the field forward. The National Institute of Environmental Health Sciences, which is part of the NIH, focuses on how environmental factors shape human health. Its monthly selections of papers highlight studies that are meaningfully advancing the field.

Aluru distinguishes the scientist and the person, but believes her determination strengthened her both. He recalls the steadiness with which she moved through setbacks, the kind of resilience that makes difficult research possible. “Basic science is a slow thing, but it is a stepping stone to future work. Remember, you cannot have Nobel prizes without bench work,” he says. He views her contributions as essential stepping stones that enable future discoveries.

What’s Next for Panlilio?

Looking ahead, Panlilio says what excites her most about her career is “the ability to have more responsibility to shape the strategy.” Her focus is not on titles or prestige but on impact. Instead of simple reading and reacting to proposals, she wants to help define where the priority lies. Instead of simply saying we should not fund this project, and maybe not fund the topic as a whole.   

Her years at the lab bench give her a perspective that many in funding roles lack. She understands when an experiment is technically impossible. When a method is more aspirational than realistic, combined with her research training, teaching experience, and leadership roles, she brings a holistic view of how science succeeds and sometimes fails.

Panlilio’s career demonstrates that equity in brain health does not begin with breakthrough drugs, instead with who interprets the science and decides what research deserves funding. Her trajectory from research to communicator to philanthropist shows what it looks like when someone with the right background and skills is matched with good morals. In a field where shortcuts are tempting, her work and story reminds us that the integrity of science depends on people at the bench, behind the screen, and in the rooms where decisions about the future of research are made.